1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Global Oxygen Therapy Devices Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape/Recent Development
4.4. Regulatory Framework
4.5. Porters Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Intensity of Rivalry
5. Global Oxygen Therapy Devices Market Overview
5.1. Market Size & Forecast by Value, 2018-2028
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Product Type
5.2.1.1. Oxygen Source Equipments
5.2.1.1.1. Oxygen Concentrator
5.2.1.1.2. Liquid oxygen device
5.2.1.1.3. Oxygen cylinders
5.2.1.2. Oxygen Delivery Devices
5.2.1.2.1. Oxygen Masks
5.2.1.2.2. Nasal Cannulas
5.2.1.2.3. Venture Masks
5.2.1.2.4. Non-Rebreather Masks
5.2.1.2.5. Bag Valve Masks
5.2.1.2.6. Other Devices
5.2.2. By Portability
5.2.2.1. Standalone Device
5.2.2.2. Portable Device
5.2.3. By Applications
5.2.3.1. COPD
5.2.3.2. Asthma
5.2.3.3. Cystic Fibrosis
5.2.3.4. Respiratory Distress Syndrome
5.2.3.5. Pneumonia
5.2.3.6. Other diseases
5.2.4. By End Users
5.2.4.1. Hospitals
5.2.4.2. Homecare Settings
5.2.4.3. Others
5.2.5. By Region
5.2.5.1. North America
5.2.5.2. Europe
5.2.5.3. The Asia Pacific
5.2.5.4. Latin America
5.2.5.5. The Middle East and Africa
6. North America Oxygen Therapy Devices Market
6.1. Market Size & Forecast by Value, 2018-2028
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Portability
6.2.3. By Application
6.2.4. By End Users
6.2.5. By Country
6.2.5.1. United States
6.2.5.2. Canada
7. Europe Oxygen Therapy Devices Market
7.1. Market Size & Forecast by Value, 2018-2028
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Portability
7.2.3. By Application
7.2.4. By End Users
7.2.5. By Country
7.2.5.1. Germany
7.2.5.2. United Kingdom
7.2.5.3. Italy
7.2.5.4. France
7.2.5.5. Spain
7.2.5.6. Rest of Europe
8. The Asia Pacific Oxygen Therapy Devices Market
8.1. Market Size & Forecast by Value, 2018-2028
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Portability
8.2.3. By Application
8.2.4. By End Users
8.2.5. By Country
8.2.5.1. China
8.2.5.2. India
8.2.5.3. Japan
8.2.5.4. South Korea
8.2.5.5. Rest of Asia Pacific
9. Latin America Oxygen Therapy Devices Market
9.1. Market Size & Forecast by Value, 2018-2028
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Portability
9.2.3. By Application
9.2.4. By End Users
9.2.5. By Country
9.2.5.1. Brazil
9.2.5.2. Mexico
9.2.5.3. Rest of Latin America
10. The Middle East & Africa Market
10.1. Market Size & Forecast by Value, 2018-2028
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Portability
10.2.3. By Application
10.2.4. By End Users
10.2.5. By Country
10.2.5.1. Saudi Arabia
10.2.5.2. UAE
10.2.5.3. South Africa
10.2.5.4. Rest of Middle East & Africa
11. Competitive Landscape
11.1. List of Key Players and Their Offerings
11.2. Market Share Analysis, 2021
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Key Strategic Development (Merger, Acquisition, Partnership.)
12. Impact of Covid-19 on Global Oxygen Therapy Devices Market Industry
13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
13.1. Linde plc
13.2. Invacare Corporation
13.3. Chart Industries
13.4. Koninklijke Philips N.V.
13.5. BD
13.6. Smiths Medical
13.7. Teleflex Incorporated
13.8. Fisher & Paykel Healthcare Limited
13.9. Drgerwerk AG & Co.
13.10. Inogen Inc.
13.11. Messer Medical
13.12. HERSILL
13.13. GCE Group
13.14. Allied Healthcare Products, Inc.
13.15. DeVilbiss Healthcare LLC
13.16. CAIRE Inc.
13.17. Medicop
13.18. Essex Industries Inc.
13.19. Taiyo Nippon Sanso Corporation
13.20. Others.
14. Key Strategic Recommendations
*Financial details of unlisted companies will be available as per data availability in final deliverable.
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable